Tag: black lung disease market overview

Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

How Has the Black Lung Disease Market Grown from 2024 to 2025?

The market size for black lung disease has seen a significant expansion over the recent years. It is anticipated to rise from $9.66 billion in 2024 to about $11.02 billion in 2025, with a compound annual growth rate (CAGR) of 14.1%. Factors such as the expansion of the coal mining industry, enhanced awareness and education, compensation and benefits, as well as legislative and legal developments are believed to be driving the growth observed in the historic period.

What Growth Rate Is Anticipated for the Black Lung Disease Market in the Coming Years?

The market for black lung disease is forecasted to expand quickly over the next few years, reaching an estimated value of $19.42 billion in 2029 with a compound annual growth rate (CAGR) of 15.2%. This projected growth within the forecast period can be credited to factors such as public health campaigns, progress in medical technologies, a rise in treatment alternatives, as well as advocacy and backing by various organizations. Significant trends to watch in this forecast period involve improved diagnostic processes, research towards prevention, access to healthcare and technological advancements.

Download The Free Sample Report Here:

https://www.thebusinessresearchcompany.com/sample.aspx?id=12988&type=smp

Who Are the Leading Companies in the Black Lung Disease Market?

Major companies operating in the black lung disease market are Pfizer Inc., Johnson and Johnson, Siemens AG, General Electric, F. Hoffmann-La Roche AG, Merck and Co. Inc., Bayer AG, Novartis AG, Sanofi S.A., AstraZeneca PLC, Melinta Therapeutics LLC, GlaxoSmithKline PLC, Medtronic PLC, Eli Lilly and Company, Boehringer Ingelheim International GmbH, Toshiba Corporation, Koninklijke Philps N.V., Mayo Clinic, Baxter International Inc., Teva Pharmaceutical Industries Ltd., Sun Pharmaceutical Industries Ltd., Perrigo Lab India Pvt. Ltd., Aurobindo Pharma Limited, Hikma Pharmaceuticals PLC, Lupin Limited.

What Are the Key Drivers of the Black Lung Disease Market?

Rise in mining activities is set to fuel the black lung disease market’s progress in the future. These activities involve the extraction of valuable minerals, ores and other geological materials from the crust of the earth. Black lung disease, affecting coal miners, is attributable to mining activities and inhalation of coal mine dust which consists of harmful carbon-containing particles. For instance, the International Energy Agency (IEA), an intergovernmental organization based in France, reported in July 2023 that there was a significant spike in critical mineral production, with an increase of 30% to $41 billion in 2022, following a 20% rise in 2021. The past five years have witnessed a sharp growth in demand for critical minerals, marked by a threefold increase in lithium consumption and a 70% surge in cobalt demand. As such, enhanced mining activities are fuelling the expansion of the black lung disease market.

An Increase in Tuberculosis Cases Fuels the Growth of the Black Lung Disease Market

 

Request For A Customized Report:

https://www.thebusinessresearchcompany.com/customise?id=12988&type=smp

What Are the Key Market Segments in the Black Lung Disease Industry?

The black lung disease market covered in this report is segmented –

1) By Type: Simple Coal Worker’s Pneumoconiosis, Complicated Coal Worker’s Pneumoconiosis, Other Types

2) By Treatment: Oxygen Therapy, Bronchodilators, Lung Transplant, Stem Cell Therapy, Other Treatment

3) By Diagnosis: Biopsy, Imaging, Full Blood Count, Pulmonary Or Lung Function Tests, Physical Examination, Other Diagnosis

4) By End Users: Hospitals And Clinics, Research Organizations And Academic Institutes, Diagnostic Centers And Labs, Other End Users

Subsegments:

1) By Simple Coal Worker’s Pneumoconiosis: Asymptomatic Simple Pneumoconiosis, Symptomatic Simple Pneumoconiosis

2) By Complicated Coal Worker’s Pneumoconiosis: Progressive Massive Fibrosis (PMF), Complicated Pneumoconiosis With Respiratory Symptoms

3) By Other Type: Mixed Dust Pneumoconiosis, Other Related Respiratory Diseases

Access The Full Report Here:

https://www.thebusinessresearchcompany.com/report/black-lung-disease-global-market-report

What Are the Key Regional Markets in the Black Lung Disease Industry?

North America was the largest region in the black lung disease market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in black lung disease market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

Purchase The Full Report Today:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=12988

This Report Delivers Insight On:

1. How big is the black lung disease market, and how is it changing globally?

2. Who are the major companies in the black lung disease market, and how are they performing?

3. What are the key opportunities and risks in the black lung disease market right now?

4. Which products or customer segments are growing the most in the black lung disease market?

5. What factors are helping or slowing down the growth of the black lung disease market?

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 2071930708

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Discover trends, market shifts, and competitive outlooks for the black lung disease industry through 2025-2034 with The Business Research Company’s reliable data and in-depth research

What is the Projected CAGR for the Black Lung Disease Market Size from 2025 to 2034?

In recent times, the market size for black lung disease has seen a swift expansion. The market is set to escalate from $9.66 billion in 2024 to $11.02 billion in 2025, with a compound annual growth rate (CAGR) of 14.1%. Factors contributing to growth during the historic period encompass the burgeoning coal mining industry, heightened awareness and education, increment in compensation and benefits, along with legislative and legal evolution.

The market size for black lung disease is anticipated to witness a fast-paced expansion in the coming years. It’s estimated to soar to $19.42 billion by 2029, with a compound annual growth rate (CAGR) of 15.2%. The expected expansion during the forecast period could be due to factors such as public health campaigns, advancements in medicine, a rise in treatment methodologies, and the support from advocacy organizations. The period will see key trends like enhanced diagnostic practices, focus on research and prevention, access to healthcare services, and technological upgrades.

Download a free sample to assess the report’s scope and structure:

https://www.thebusinessresearchcompany.com/sample.aspx?id=12988&type=smp

What are the Fundamental Drivers and Innovations Shaping the Black Lung Disease Market?

The black lung disease market is anticipated to witness growth due to the rise in mining activities. Mining, which involves extracting valuable geological materials, minerals, and ores from the earth’s crust, is responsible for black lung disease. This respiratory condition results from inhaling coal mine dust full of harmful carbon particles, affecting coal miners significantly. The International Energy Agency (IEA), a France-based intergovernmental organization, reported in July 2023 a substantial surge in critical mineral production. There was a 30% increase, reaching $41 billion in 2022, which succeeded a 20% rise in 2021. Over half a decade, critical minerals demand has risen significantly, with lithium consumption tripling and cobalt demand increasing by 70%. Thus, the black lung disease market is being propelled by burgeoning mining activities. As tuberculosis prevalence rises, so is the growth of the black lung disease market. Tuberculosis is a bacterial infection chiefly due to Mycobacterium tuberculosis. When an infected person coughs or sneezes, the disease spreads through the air, leading to symptoms like coughing, fever, weight loss, and exhaustion. Tuberculosis (TB) prevalence is a contributing factor to black lung disease – individuals suffering from TB have a higher risk of contracting black lung disease as their exposure to coal dust is likely to be more frequent. In March 2023, the US-based national public health organization, the Centers for Disease Control and Prevention, reported an increase in tuberculosis (TB) cases in the US. There were 8,300 cases in 2022, rising from 7,874 in 2021. Consequently, the rising prevalence of tuberculosis fuels the black lung disease market growth.

How Is the Black Lung Disease Market Segmented?

The black lung disease market covered in this report is segmented –

1) By Type: Simple Coal Worker’s Pneumoconiosis, Complicated Coal Worker’s Pneumoconiosis, Other Types

2) By Treatment: Oxygen Therapy, Bronchodilators, Lung Transplant, Stem Cell Therapy, Other Treatment

3) By Diagnosis: Biopsy, Imaging, Full Blood Count, Pulmonary Or Lung Function Tests, Physical Examination, Other Diagnosis

4) By End Users: Hospitals And Clinics, Research Organizations And Academic Institutes, Diagnostic Centers And Labs, Other End Users

Subsegments:

1) By Simple Coal Worker’s Pneumoconiosis: Asymptomatic Simple Pneumoconiosis, Symptomatic Simple Pneumoconiosis

2) By Complicated Coal Worker’s Pneumoconiosis: Progressive Massive Fibrosis (PMF), Complicated Pneumoconiosis With Respiratory Symptoms

3) By Other Type: Mixed Dust Pneumoconiosis, Other Related Respiratory Diseases

Request customized data on this market:

https://www.thebusinessresearchcompany.com/customise?id=12988&type=smp

Which Regions Are Driving the Next Phase of the Black Lung Disease Market Growth?

North America was the largest region in the black lung disease market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in black lung disease market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

View the full report here:

https://www.thebusinessresearchcompany.com/report/black-lung-disease-global-market-report

How Is the Black Lung Disease Market Defined and What Are Its Core Parameters?

Black lung disease is a chronic and potentially fatal lung disease that affects coal miners and other individuals who work in coal mines or are exposed to coal dust. The disease is characterized by the accumulation of coal dust particles in the lungs, which can lead to inflammation, scarring and damage to lung tissues.

Purchase the full report and get a swift delivery:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=12988

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

2025 Market Reports Update: Market Size Forecasts to 2034, Key Trends, Leading Players, and Top Regions – Get Ahead of the Competition Today!

How Are Key Drivers Contributing to the Growth and Expansion of the Black Lung Disease Market?

The black lung disease market is expected to experience further growth due to the increase in mining activities. Mining consists of extracting precious minerals, ores, and other geologic materials from the earth’s surface. Black lung disease ensues from engaging in mining activities and inhaling coal dust filled with harmful carbon particles, affecting coal miners. For instance, the International Energy Agency, a France-based intergovernmental organization, reported in July 2023 that critical mineral production witnessed a considerable surge, increasing by 30% to reach $41 billion in 2022 after an initial 20% increase in 2021. The demand for these critical minerals over the past five years has skyrocketed, with lithium consumption tripling and cobalt demand increasing by 70%. Hence, the black lung disease market is greatly influenced by the rise in mining activities.

Black Lung Disease Market Driver: Rising Tuberculosis Prevalence Fuels Black Lung Disease Market Growth

 

Get Your Free Sample Report Now – Explore Exclusive Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=12988&type=smp

#What is the Projected CAGR for the Black Lung Disease Market Size from 2025 to 2034?

In recent times, the black lung disease market has seen rapid expansion. It is projected to rise from $9.66 billion in 2024 to $11.02 billion in 2025, representing a compound annual growth rate (CAGR) of 14.1%. Factors contributing to this growth during the historical period include the expansion of the coal mining industry, increased awareness and education, compensation and benefits enhancements, along with legislative and legal advancements.

Expectations suggest that the market size for black lung disease will experience a swift expansion in the coming years. The market is projected to enlarge to $19.42 billion by 2029, with a compound annual growth rate (CAGR) of 15.2%. The anticipated growth during the forecast period can be accredited to various factors such as public health endeavors, progress in medicine, the surge in treatment alternatives, and the impact of advocacy and support groups. Leading trends during this forecast period encompass sophisticated diagnostic methods, research and prevention efforts, accessibility to healthcare, and advancements in technology.

You can Directly Purchase the Report Here:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=12988

What New Market Trends Are Reshaping theBlack Lung Disease Market and Its Opportunities?

Who Are the Leading Market Players Fueling Growth in the Black Lung Disease Market Trend?

Major companies operating in the black lung disease market are Pfizer Inc., Johnson and Johnson, Siemens AG, General Electric, F. Hoffmann-La Roche AG, Merck and Co. Inc., Bayer AG, Novartis AG, Sanofi S.A., AstraZeneca PLC, Melinta Therapeutics LLC, GlaxoSmithKline PLC, Medtronic PLC, Eli Lilly and Company, Boehringer Ingelheim International GmbH, Toshiba Corporation, Koninklijke Philps N.V., Mayo Clinic, Baxter International Inc., Teva Pharmaceutical Industries Ltd., Sun Pharmaceutical Industries Ltd., Perrigo Lab India Pvt. Ltd., Aurobindo Pharma Limited, Hikma Pharmaceuticals PLC, Lupin Limited.

Order Your Report Now For A Swift Delivery:

https://www.thebusinessresearchcompany.com/report/black-lung-disease-global-market-report

How is the Global Black Lung Disease Market Segemented?

The black lung disease market covered in this report is segmented –

1) By Type: Simple Coal Worker’s Pneumoconiosis, Complicated Coal Worker’s Pneumoconiosis, Other Types

2) By Treatment: Oxygen Therapy, Bronchodilators, Lung Transplant, Stem Cell Therapy, Other Treatment

3) By Diagnosis: Biopsy, Imaging, Full Blood Count, Pulmonary Or Lung Function Tests, Physical Examination, Other Diagnosis

4) By End Users: Hospitals And Clinics, Research Organizations And Academic Institutes, Diagnostic Centers And Labs, Other End Users

Subsegments:

1) By Simple Coal Worker’s Pneumoconiosis: Asymptomatic Simple Pneumoconiosis, Symptomatic Simple Pneumoconiosis

2) By Complicated Coal Worker’s Pneumoconiosis: Progressive Massive Fibrosis (PMF), Complicated Pneumoconiosis With Respiratory Symptoms

3) By Other Type: Mixed Dust Pneumoconiosis, Other Related Respiratory Diseases

Gain Exclusive Market Insights—Customize Your Research Report Today for Fast Delivery!

https://www.thebusinessresearchcompany.com/customise?id=12988&type=smp

Which Geographics are Influencing the Growth of the Black Lung Disease Market?

North America was the largest region in the black lung disease market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in black lung disease market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

Browse Through More Reports Similar to the Global Black Lung Disease Market 2025, By The Business Research Company:

Blockchain In Agriculture And Food Supply Chain Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/blockchain-in-agriculture-and-food-supply-chain-global-market-report

Web 3.0 Blockchain Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/web-3-0-blockchain-global-market-report

Blockchain In Banking And Financial Services Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/blockchain-in-banking-and-financial-services-global-market-report

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Contact us at:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Found this article helpful? Share it on:

Updated 2025 Market Reports Released: Trends, Forecasts to 2034 – Early Purchase Your Competitive Edge Today!

How has the black lung disease market grown in recent years?

The market size for black lung disease has seen brisk growth in the past several years. It’s set to expand from $9.66 billion in 2024 to $11.02 billion in 2025, registering a compound annual growth rate (CAGR) of 14.1%. This escalated growth during the historic period can be credited to factors such as expansion of the coal mining industry, increased awareness and education, improved compensation and benefits, along with legislative and legal advancements.

How is the black lung disease market size expected to evolve during the forecast period?

The market for black lung disease is forecasted to expand swiftly in the coming years, projecting a value of $19.42 billion by 2029, exhibiting a compound annual growth rate (CAGR) of 15.2%. The projected increase over the forecast period can be credited to initiatives in public health, advancements in the medical field, a rise in treatment alternatives, and advocacy and support groups. Key trends in this period comprise of progressive diagnostic procedures, investigations and prevention, accessibility to healthcare, and advances in technology.

Get your black lung disease market report here!

https://www.thebusinessresearchcompany.com/report/black-lung-disease-global-market-report

Which key drivers are propelling the black lung disease market’s growth?

The expansion of mining activities is anticipated to spur the progression of the black lung disease market. This progression is largely due to the processes involved in mining, which necessitate the extraction of valuable minerals and other geological resources from the earth’s crust. The occurrence of black lung disease is predominantly attributed to these mining processes, specifically the inhalation of coal mine dust that carries harmful carbon-containing particles and poses a serious health risk to coal miners. A pertinent example would be the significant escalation in critical mineral production observed in July 2023. The International Energy Agency (IEA), a France-based intergovernmental company, recorded an increase of 30% to reach the $41 billion mark in 2022, a considerable gain of 20% from 2021. The past half-decade has seen a significant surge in critical minerals demand, evidenced by a threefold rise in lithium consumption and a 70% jump in cobalt demand. Hence, the expansion of mining activities serves as a stimulant for the black lung disease market’s progression. The rise in tuberculosis instances is expected to stoke the advancement of the black lung disease market. Tuberculosis, commonly resulting from the bacterium Mycobacterium tuberculosis, is primarily a respiratory infection that spreads when an infected individual coughs or sneezes. The emergence of symptoms such as coughing, fever, fatigue, and weight loss, often indicate the presence of this ailment. The inevitable correlation between an increasing tuberculosis prevalence and black lung disease arises as individuals afflicted with tuberculosis possess a heightened risk of developing black lung disease due to intensified exposure to coal dust. A case in point would be the figures released by the Centers for Disease Control and Prevention, an American public health organization, in March 2023. These figures indicated a rise in tuberculosis cases in the US from 7,874 in 2021 to 8,300 in 2022. Therefore, the surge in tuberculosis prevalence serves as a catalyst for the advancement of the black lung disease market.

What are the market segments in the black lung disease industry?

The black lung disease market covered in this report is segmented –

1) By Type: Simple Coal Worker’s Pneumoconiosis, Complicated Coal Worker’s Pneumoconiosis, Other Types

2) By Treatment: Oxygen Therapy, Bronchodilators, Lung Transplant, Stem Cell Therapy, Other Treatment

3) By Diagnosis: Biopsy, Imaging, Full Blood Count, Pulmonary Or Lung Function Tests, Physical Examination, Other Diagnosis

4) By End Users: Hospitals And Clinics, Research Organizations And Academic Institutes, Diagnostic Centers And Labs, Other End Users

Subsegments:

1) By Simple Coal Worker’s Pneumoconiosis: Asymptomatic Simple Pneumoconiosis, Symptomatic Simple Pneumoconiosis

2) By Complicated Coal Worker’s Pneumoconiosis: Progressive Massive Fibrosis (PMF), Complicated Pneumoconiosis With Respiratory Symptoms

3) By Other Type: Mixed Dust Pneumoconiosis, Other Related Respiratory Diseases

Get your free sample now – explore exclusive market insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=12988&type=smp

Which leading companies are shaping the growth of the black lung disease market?

Major companies operating in the black lung disease market are Pfizer Inc., Johnson and Johnson, Siemens AG, General Electric, F. Hoffmann-La Roche AG, Merck and Co. Inc., Bayer AG, Novartis AG, Sanofi S.A., AstraZeneca PLC, Melinta Therapeutics LLC, GlaxoSmithKline PLC, Medtronic PLC, Eli Lilly and Company, Boehringer Ingelheim International GmbH, Toshiba Corporation, Koninklijke Philps N.V., Mayo Clinic, Baxter International Inc., Teva Pharmaceutical Industries Ltd., Sun Pharmaceutical Industries Ltd., Perrigo Lab India Pvt. Ltd., Aurobindo Pharma Limited, Hikma Pharmaceuticals PLC, Lupin Limited.

Unlock exclusive market insights – purchase your research report now for a swift delivery!

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=12988

Which geographic areas are influencing the growth of the black lung disease market?

North America was the largest region in the black lung disease market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in black lung disease market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

Browse Through More Similar Reports By The Business Research Company:

Blockchain In Agriculture And Food Supply Chain Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/blockchain-in-agriculture-and-food-supply-chain-global-market-report

Web 3.0 Blockchain Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/web-3-0-blockchain-global-market-report

Blockchain In Banking And Financial Services Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/blockchain-in-banking-and-financial-services-global-market-report

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Contact us at:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Found this article helpful? Share it on:

Updated 2025 Market Reports Released: Trends, Forecasts to 2034 – Early Purchase Your Competitive Edge Today!

What Future CAGR is Anticipated for the Black Lung Disease Market Over the 2025–2034 Period?

Over the recent years, there’s been a substantial escalation in the market size of black lung disease. The market is anticipated to expand from $9.66 billion in 2024 to $11.02 billion in 2025, marking an impressive compound annual growth rate (CAGR) of 14.1%. This significant growth during the historic period is largely a result of the expansion of the coal mining industry, heightened awareness and education, increased compensation and benefits, and advancements in legislative and legal platforms.

The market size for black lung disease is projected to witness accelerated expansion in the coming years, reaching $19.42 billion by 2029 with a compound annual growth rate (CAGR) of 15.2%. The predicted surge during the forecast period is largely due to factors like initiatives in public health, advancements in medicinal sciences, proliferation of treatment choices, and the influence of advocacy and sustenance groups. The forecast period will also probably see significant trends such as the application of advanced diagnostic methods, increased investment in research and prevention, improved healthcare accessibility, and progress in technology.

What Industry-Specific Factors Are Fueling the Growth of the black lung disease Market?

Higher mining activities are anticipated to fuel the black lung disease market’s growth. These activities entail extracting valuable minerals, ores, and other geological materials from the earth. Black lung disease stems from mining undertakings and inhaling coal mine dust, which is laden with harmful carbon particles, severely impacting coal miners. For example, the International Energy Agency (IEA), a France-based intergovernmental organization, reported in July 2023, that the production of critical minerals witnessed a sizeable boost, growing by 30% to reach $41 billion in 2022, a rise from a 20% growth in 2021. The past five years have seen the demand for critical minerals increase considerably, with lithium consumption tripling and cobalt demand going up by 70%. Thus, higher mining activities are leading to the growth of the black lung disease market. The rise in tuberculosis prevalence is anticipated to fuel the growth of the black lung disease market. Tuberculosis is a bacterial infection mainly caused by Mycobacterium tuberculosis that spreads when an infected person coughs or sneezes, leading to symptoms such as coughing, fever, weight loss, and fatigue. The rise in tuberculosis prevalence plays a role in black lung disease as individuals with tuberculosis carry a higher risk of developing black lung disease and are more likely exposed to coal dust. In March 2023, the Centers for Disease Control and Prevention, a US-based public health agency, reported 8,300 cases of tuberculosis in 2022 in the US, an increase from 7,874 cases in 2021. Hence, the rise in tuberculosis prevalence is fuelling the black lung disease market growth.

Request Your Free Black Lung Disease Market Report Sample Now!

https://www.thebusinessresearchcompany.com/sample.aspx?id=12988&type=smp

Who Are the Influential Players Fueling Innovation and Growth in the Black Lung Disease Market?

Major companies operating in the black lung disease market are:

• Pfizer Inc._x000D_

• Johnson and Johnson_x000D_

• Siemens AG_x000D_

• General Electric_x000D_

• F. Hoffmann-La Roche AG_x000D_

What Impact Are Industry Trends Having on the Black Lung Disease Market’s Future Prospects?

Pre-order Your Report for Quick and Easy Delivery!

https://www.thebusinessresearchcompany.com/report/black-lung-disease-global-market-report

Which Industry Segments Are Leading the Development and Expansion of the Black Lung Disease Market?

The black lung disease market covered in this report is segmented –

1) By Type: Simple Coal Worker’s Pneumoconiosis, Complicated Coal Worker’s Pneumoconiosis, Other Types

2) By Treatment: Oxygen Therapy, Bronchodilators, Lung Transplant, Stem Cell Therapy, Other Treatment

3) By Diagnosis: Biopsy, Imaging, Full Blood Count, Pulmonary Or Lung Function Tests, Physical Examination, Other Diagnosis

4) By End Users: Hospitals And Clinics, Research Organizations And Academic Institutes, Diagnostic Centers And Labs, Other End Users

Subsegments:

1) By Simple Coal Worker’s Pneumoconiosis: Asymptomatic Simple Pneumoconiosis, Symptomatic Simple Pneumoconiosis

2) By Complicated Coal Worker’s Pneumoconiosis: Progressive Massive Fibrosis (PMF), Complicated Pneumoconiosis With Respiratory Symptoms

3) By Other Type: Mixed Dust Pneumoconiosis, Other Related Respiratory Diseases

What Regions Are Leading the Growth Trajectory of the Black Lung Disease Market?

North America was the largest region in the black lung disease market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in black lung disease market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

What Are the Defining Aspects of the Black Lung Disease Market Landscape?

Black lung disease is a chronic and potentially fatal lung disease that affects coal miners and other individuals who work in coal mines or are exposed to coal dust. The disease is characterized by the accumulation of coal dust particles in the lungs, which can lead to inflammation, scarring and damage to lung tissues.

Browse Through More Similar Reports By The Business Research Company:

Blockchain In Agriculture And Food Supply Chain Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/blockchain-in-agriculture-and-food-supply-chain-global-market-report

Web 3.0 Blockchain Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/web-3-0-blockchain-global-market-report

Blockchain In Banking And Financial Services Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/blockchain-in-banking-and-financial-services-global-market-report

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Contact us at:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Found this article helpful? Share it on: